Advantis Corp. Developing Own Brand of Edibles, CBD Product Lines

NEWPORT BEACH, CA, Oct. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) revealed today that they have been developing its own brand of cannabis-infused edibles, Amster Edibles. Advantis also revealed that it is close to releasing a full line of self-branded CBD products.

“Last week we announced that we are receiving pallet sized orders for Amster-Can edible packaging,” CEO, Darren Cherry, explained. “Now I can reveal that we have been working on our own brand of edibles with our partner Natural Elements.  Demand for edibles has always existed, but now we have the see-through cans and are completing a thorough product testing process; we will enter the marketplace with only the highest quality edibles, thanks to our expanding list of partners. Gummies will likely be the first, and they are deliciously effective.”

Cherry says that there are already orders for the gummy candies, and he anticipates being able to distribute the entire line of edibles and CBD products through its existing product pipeline. “Edibles and CBD products have presented a real opportunity for Amst,er-Can to capitalize on the greater packaging need. There is a much higher consumption rate with edibles; an eighth may last someone a week, whereas an edible, can be consumed in a day. We’ve gone from three thousand-unit orders to pallet size orders, just because of the growing demand for edibles -- that’s more than a tripling of orders.” Cherry mentioned that finalizing the Orange County location will enable the company to more rapidly expand its capacity, then said, “We have much in the works and have some exciting news we expect to announce next week.”

Cherry highlighted recent developments with Kimo, since announcing his contributions to the company last week. “We love Kimo, and Kimo really loves our products,” Cherry said. “He has opened my eyes in a lot of ways. Many current and retired professional athletes have found cannabis to be an effective replacement for doctor-prescribed opiates. A lifetime of injury and pain in every sport leads almost every athlete toward pain killers and anti-inflammatories; out of necessity to deal with an ailment that ultimately cannot be healed.” According to a USA today article written in April of this year, former athletes estimate that about 80% of NFL and NBA players use or have used marijuana; mostly for pain. “Kimo has an extensive network of friends and colleagues that span every sport, and he is opening the door to his network,” Cherry related. “I am proud to be able to help athletes find a healthier way to manger their pain. I will also be proud as additional athletes join the Advantis family to represent and attest to the value and quality of our product lineup.”

Advantis wishes to thank Investors Hangout for mentioning the company in their podcast. 

Links to Advantis pictures and websites can be found on Facebook and Instagram pages, and at, and 

About Advantis Corporation

Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes partnerships with businesses that develop and sell proprietary pain management, and consumer products and services. 

Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.


Contact Data